Copyright Reports & Markets. All rights reserved.

Global PNH and aHUS Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of PNH and aHUS by Type
    • 1.3.1 Overview: Global PNH and aHUS Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global PNH and aHUS Consumption Value Market Share by Type in 2023
    • 1.3.3 Soliris
    • 1.3.4 Ultomiris
  • 1.4 Global PNH and aHUS Market by Application
    • 1.4.1 Overview: Global PNH and aHUS Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 PNH
    • 1.4.3 aHUS
  • 1.5 Global PNH and aHUS Market Size & Forecast
  • 1.6 Global PNH and aHUS Market Size and Forecast by Region
    • 1.6.1 Global PNH and aHUS Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global PNH and aHUS Market Size by Region, (2019-2030)
    • 1.6.3 North America PNH and aHUS Market Size and Prospect (2019-2030)
    • 1.6.4 Europe PNH and aHUS Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific PNH and aHUS Market Size and Prospect (2019-2030)
    • 1.6.6 South America PNH and aHUS Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa PNH and aHUS Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Alexion Pharmaceuticals
    • 2.1.1 Alexion Pharmaceuticals Details
    • 2.1.2 Alexion Pharmaceuticals Major Business
    • 2.1.3 Alexion Pharmaceuticals PNH and aHUS Product and Solutions
    • 2.1.4 Alexion Pharmaceuticals PNH and aHUS Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Alexion Pharmaceuticals Recent Developments and Future Plans
  • 2.2 Alnylam Pharmaceuticals
    • 2.2.1 Alnylam Pharmaceuticals Details
    • 2.2.2 Alnylam Pharmaceuticals Major Business
    • 2.2.3 Alnylam Pharmaceuticals PNH and aHUS Product and Solutions
    • 2.2.4 Alnylam Pharmaceuticals PNH and aHUS Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
  • 2.3 Omeros Corporation
    • 2.3.1 Omeros Corporation Details
    • 2.3.2 Omeros Corporation Major Business
    • 2.3.3 Omeros Corporation PNH and aHUS Product and Solutions
    • 2.3.4 Omeros Corporation PNH and aHUS Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Omeros Corporation Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global PNH and aHUS Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of PNH and aHUS by Company Revenue
    • 3.2.2 Top 3 PNH and aHUS Players Market Share in 2023
    • 3.2.3 Top 6 PNH and aHUS Players Market Share in 2023
  • 3.3 PNH and aHUS Market: Overall Company Footprint Analysis
    • 3.3.1 PNH and aHUS Market: Region Footprint
    • 3.3.2 PNH and aHUS Market: Company Product Type Footprint
    • 3.3.3 PNH and aHUS Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global PNH and aHUS Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global PNH and aHUS Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global PNH and aHUS Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global PNH and aHUS Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America PNH and aHUS Consumption Value by Type (2019-2030)
  • 6.2 North America PNH and aHUS Market Size by Application (2019-2030)
  • 6.3 North America PNH and aHUS Market Size by Country
    • 6.3.1 North America PNH and aHUS Consumption Value by Country (2019-2030)
    • 6.3.2 United States PNH and aHUS Market Size and Forecast (2019-2030)
    • 6.3.3 Canada PNH and aHUS Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico PNH and aHUS Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe PNH and aHUS Consumption Value by Type (2019-2030)
  • 7.2 Europe PNH and aHUS Consumption Value by Application (2019-2030)
  • 7.3 Europe PNH and aHUS Market Size by Country
    • 7.3.1 Europe PNH and aHUS Consumption Value by Country (2019-2030)
    • 7.3.2 Germany PNH and aHUS Market Size and Forecast (2019-2030)
    • 7.3.3 France PNH and aHUS Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom PNH and aHUS Market Size and Forecast (2019-2030)
    • 7.3.5 Russia PNH and aHUS Market Size and Forecast (2019-2030)
    • 7.3.6 Italy PNH and aHUS Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific PNH and aHUS Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific PNH and aHUS Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific PNH and aHUS Market Size by Region
    • 8.3.1 Asia-Pacific PNH and aHUS Consumption Value by Region (2019-2030)
    • 8.3.2 China PNH and aHUS Market Size and Forecast (2019-2030)
    • 8.3.3 Japan PNH and aHUS Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea PNH and aHUS Market Size and Forecast (2019-2030)
    • 8.3.5 India PNH and aHUS Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia PNH and aHUS Market Size and Forecast (2019-2030)
    • 8.3.7 Australia PNH and aHUS Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America PNH and aHUS Consumption Value by Type (2019-2030)
  • 9.2 South America PNH and aHUS Consumption Value by Application (2019-2030)
  • 9.3 South America PNH and aHUS Market Size by Country
    • 9.3.1 South America PNH and aHUS Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil PNH and aHUS Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina PNH and aHUS Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa PNH and aHUS Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa PNH and aHUS Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa PNH and aHUS Market Size by Country
    • 10.3.1 Middle East & Africa PNH and aHUS Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey PNH and aHUS Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia PNH and aHUS Market Size and Forecast (2019-2030)
    • 10.3.4 UAE PNH and aHUS Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 PNH and aHUS Market Drivers
  • 11.2 PNH and aHUS Market Restraints
  • 11.3 PNH and aHUS Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 PNH and aHUS Industry Chain
  • 12.2 PNH and aHUS Upstream Analysis
  • 12.3 PNH and aHUS Midstream Analysis
  • 12.4 PNH and aHUS Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
    According to our (Global Info Research) latest study, the global PNH and aHUS market size was valued at US$ 5668 million in 2023 and is forecast to a readjusted size of USD 8625 million by 2030 with a CAGR of 6.2% during review period.
    United States is the largest consumption place, with a consumption market share nearly 52.1% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 26.2%.
    This report is a detailed and comprehensive analysis for global PNH and aHUS market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global PNH and aHUS market size and forecasts, in consumption value ($ Million), 2019-2030
    Global PNH and aHUS market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global PNH and aHUS market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global PNH and aHUS market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for PNH and aHUS
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global PNH and aHUS market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Omeros Corporation, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    PNH and aHUS market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    PNH and aHUS market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Soliris
    Ultomiris
    Market segment by Application
    PNH
    aHUS
    Market segment by players, this report covers
    Alexion Pharmaceuticals
    Alnylam Pharmaceuticals
    Omeros Corporation
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe PNH and aHUS product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of PNH and aHUS, with revenue, gross margin, and global market share of PNH and aHUS from 2019 to 2024.
    Chapter 3, the PNH and aHUS competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and PNH and aHUS market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of PNH and aHUS.
    Chapter 13, to describe PNH and aHUS research findings and conclusion.

    Buy now